Produttore professionale di linee di riempimento asettico - Soluzioni chiavi in mano

Marya Cartridge Filling Line Shipped to Ukraine

MARYA cartridge filling line for Ukraine has successfully passed remote Factory Acceptance Testing (FAT) in late May, marking a key milestone before shipment. The client's team verified full line performance via online conference, and all test items were approved, confirming that the aseptic filling solution fully meets their pharmaceutical production requirements and regulatory standards.

The line integrates an ultrasonic cartridge washing machine, a sterilization tunnel, a filling & capping machine, and a complete CIP/SIP system. The washer uses ultrasonic preโ€‘cleaning with threeโ€‘water, threeโ€‘air rinsing, achieving a capacity of up to 220 cartridges per minute. The highโ€‘speed filling & capping machine runs 24/7 at a stable output of 200 cartridges per minute. It adopts twoโ€‘stage filling, full servo drive and laser liquid level detection to achieve 100% fill volume inspection and highโ€‘precision production. The entire line is designed and manufactured in accordance with GMP requirements, customized for 1.8โ€ฏml cartridges.

Following shipment, Marya's engineering team will travel to Ukraine to carry out onโ€‘site installation, commissioning, and Site Acceptance Testing (SAT), along with comprehensive training on fullโ€‘line operation and routine maintenance. This endโ€‘toโ€‘end support ensures stable, reliable operation after commissioning and empowers the client's team to independently manage daily production and maintenance.

From FAT approval to shipment preparation and postโ€‘delivery SAT, Maya provides a fullโ€‘process guarantee covering every stage from factory acceptance to longโ€‘term stable production. Our oneโ€‘stop pharmaceutical equipment service ensures strict quality control during onโ€‘site installation and sustained longโ€‘term performance, delivering continuous technical training and responsive afterโ€‘sales support to our Ukrainian partner. This project marks another milestone in our expanding footprint in the Eastern European pharmaceutical market.